Evidence map›Paper›PMID 19835949›Full record

ArticleMolecular and cellular probes2010

Disease progression and solid tumor survival: a transcriptome decoherence model.

Adrian E Platts, Claudia Lalancette, Benjamin R Emery, Douglas T Carrell, Stephen A Krawetz

Abstract read
In one paragraph

Article in Molecular and cellular probes, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Energy Medicine: Current Status and Future Perspectives.Global advances in health and medicine · 2019
    Article
  2. Article
  3. The sperm nucleus: chromatin, RNA, and the nuclear matrix.Reproduction (Cambridge, England) · 2011
    Review
  4. The role of the blood transcriptome in innate inflammation and stroke.Annals of the New York Academy of Sciences · 2010
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Adrian E PlattsThe Center for Molecular Medicine and Genetics, Wayne State University School of Medicine, Detroit, MI 48201, USA.
Claudia Lalancette
Benjamin R Emery
Douglas T Carrell
Stephen A Krawetz

Funding

Proteolytic Pathways in Progression of Pre-Malignant Breast DiseaseR01CA131990 · NCI · WAYNE STATE UNIVERSITY · PI MATTINGLY, RAYMOND R, SLOANE, BONNIE F · 2008 to 2013
$1.9M
NCI NIH HHS R01 CA131990NCI NIH HHS R01CA131990-01
6 · The paper itself

Abstract

Networks of genes are typically generated from expression changes observed between control and test conditions. Nevertheless, within a single control state many genes show expression variance across biological replicates. These transcripts, typically termed unstable, are usually excluded from analyses because their behavior cannot be reconciled with biological constraints. Grouped as pairs of covariant genes they can however show a consistent response to the progression of a disease. We present a model of coherence arising from sets of covariant genes that was developed in-vitro then tested against a range of solid tumors. DGPMs, Decoherence Gene Pair Models, showed changes in network topology reflective of the metastatic transition. Across a range of solid tumor studies the model generalizes to reveal a richly connected topology of networks in healthy tissues that becomes sparser as the disease progresses reaching a minimum size in the advanced tumors with minim survivability.

Indexed as

Disease ProgressionGene Expression ProfilingModels, TheoreticalAstrocytomaBiomarkers, TumorBreast NeoplasmsCell CycleCell DifferentiationFemaleGlioblastomaHumansMaleNeoplasmsProstatic NeoplasmsUrinary Bladder NeoplasmsBiomarkers, Tumor

Identifiers

PMID19835949
PMCPMC2818311

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.